Sacral neuromodulation vs botulinum toxin A in refractory idiopathic overactive bladder: review of cost-effectiveness ev
- PDF / 167,319 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 67 Downloads / 203 Views
		    73-5503/20/0868-0001/$14.95 Adis © 2020 Springer Nature Switzerland AG. All rights reserved
 
 PharmacoEconomics & Outcomes News 12 Dec 2020 No. 868
 
 1		
Data Loading...
 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	 
	